Large-scale testing (Phase 3)Study completedNCT00943657What this trial is testingYearly Strain Variation Study, 2009/2010Who this might be right forInfluenzaSeasonal Influenza Alachua Government Services, Inc. 110
Large-scale testing (Phase 3)Study completedNCT07672626What this trial is testingSafety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose BoosterWho this might be right forVaccine Jiangsu Province Centers for Disease Control and Prevention 1,200
Not applicableLooking for participantsNCT07097155What this trial is testingAvocado Consumption and Cellular Aging in Breast Cancer SurvivorsWho this might be right forTelomere LengthBreast Cancer Females Institut Investigacio Sanitaria Pere Virgili 120
Early research (Phase 1)Study completedNCT00599443What this trial is testingSafety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 YearsWho this might be right forHealthy Solvay Pharmaceuticals 120
Not applicableLooking for participantsNCT07509333What this trial is testingMDT-Based Umbrella Decision Model for Geriatric Lung Cancer PatientsWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma West China Hospital 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07311148What this trial is testingA Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and OlderWho this might be right forHerpes Zoster (HZ)ShinglesVZV+1 more Guangzhou Patronus Biotech Co., Ltd. 840
Large-scale testing (Phase 3)Study completedNCT00416208What this trial is testingConsolidation Therapy With Bortezomib in Elderly Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Janssen-Cilag G.m.b.H 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07012980What this trial is testingGlofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCLWho this might be right forDiffuse Large B-Cell Lymphoma Shanghai Zhongshan Hospital 38
Testing effectiveness (Phase 2)Looking for participantsNCT06846489What this trial is testingAcalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma (MCL) Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT00003113What this trial is testingOral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's LymphomasWho this might be right forLymphoma Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT04383574What this trial is testingSafety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)Who this might be right forCOVID-19 Sinovac Life Sciences Co., Ltd. 422
Large-scale testing (Phase 3)UnknownNCT02767674What this trial is testingTrial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma The First Affiliated Hospital with Nanjing Medical University 258
Early research (Phase 1)Enrolling By InvitationNCT07633197What this trial is testingA Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)Who this might be right forHerpes Changchun BCHT Biotechnology Co. 120
Early research (Phase 1)Study completedNCT00783926What this trial is testingPhase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)Who this might be right forInfluenzaPandemic Influenza Alachua Government Services, Inc. 422
Large-scale testing (Phase 3)Study completedNCT00144755What this trial is testingR-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large Cell Lymphoma Lymphoma Study Association 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT06642558What this trial is testingSafety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and AboveWho this might be right forRespiratory Syncytial Virus (RSV) MAXVAX Biotechnology Limited Liability Company 522
Testing effectiveness (Phase 2)Study completedNCT01766921What this trial is testingSafety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly SubjectsWho this might be right forPandemic H5N1 Influenza Novartis Vaccines 1,393
Testing effectiveness (Phase 2)Study completedNCT00482261What this trial is testingLow Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for MyelosuppressionWho this might be right forMultiple Myeloma Peter MacCallum Cancer Centre, Australia 150
Not applicableUnknownNCT05809180What this trial is testingPro-miniCHOP-like Regimen for Treatment-naive Elderly PatientsWho this might be right forDiffuse Large B Cell Lymphoma The First Affiliated Hospital of Soochow University 35
Testing effectiveness (Phase 2)Study completedNCT01342796What this trial is testingHumoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy SubjectsWho this might be right forSeasonal InfluenzaInfluenzaInfluenza Due to Unspecified Influenza Virus+1 more Novartis Vaccines 84